Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SHINGRIX
- Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
- Effect of MTX Discontinuation on Shingrix Response in RA
- Shingrix In Recipients of Allogeneic Transplants
- Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- VZV in the Enteric Nervous System: Pathogenesis and Consequences
- Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial
- Vaccine Responses in Patients With B Cell Malignancies
- Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years
- Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents
- VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
- Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
Clinical trials list
click for details